For condition: Papulopustular Rosacea
For condition: Rosacea
The Papulopustular Rosacea Research Study (24 Weeks)
Study Summary
Who Can Participate?
Adults aged ≥ 18 years who have papulopustular rosacea, may be eligible.
Inclusion Criteria:
• A clinical diagnosis of papulopustular rosacea (PPR)
• Moderate to severe disease
• Presence of 15 – 60 inflammatory facial lesions at screening, with at least 15 lesions present at Day 1 (baseline)
• Documented inadequate response to at least one prior oral systemic antibiotic therapy for rosacea, with or without
adjunctive topical treatment (such as cleansers and moisturizers), within the past five years
Study Details:
• Participants will have regular visits with study doctors who are specialized in treating papulopustular rosacea
• Blood and/or urine samples will be collected for evaluation at specified time-points
• Participants will receive investigational oral medication (active study drug) or placebo
• Reimbursement for study-related expenses may be provided
How Long Will the Study Last?
• Participation will last about 24 weeks and involve about 9 visits to the study research site
General Info:
• Completing a registration form does not mean that you will enter the study; other eligibility criteria may apply
• Once you fill out a registration form you will be contacted by RT.com to collect additional information
• Should you no longer wish to participate in the study, you may withdraw your consent at any time
• There is no cost to participate or receive study medication
For more information about this trial, please visit ClinicalTrials.gov
